RMD — Recent News Coverage
All news mentioning RMD in ESEN's AI-graded feed
News stories with RMD as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on RMD. See /coverage/RMD for the 30-day aggregate.
RASKMEDIA.COM.AU
·
2026-06-17
NEUTRAL
NEUTRAL
CORR0.42
Are Resmed CDI (ASX:RMD) shares good value in 2026?
$RMD
◈ ESEN AI
This article presents a valuation framework for ResMed (RMD), a healthcare technology company, focused on six quantitative metrics for 2026 analysis. The piece is educational in nature, offering investors a structured a…
RASKMEDIA.COM.AU
·
2026-06-14
LOW
NEUTRAL
CORR0.45
I’m keeping an eye on RMD shares in 2026
$RMD
$QBE
◈ ESEN AI
ResMed (RMD) and QBE Insurance have attracted analyst attention heading into 2026, with both equities flagged for valuation reassessment. The piece suggests a forward-looking lens on these dual-sector plays—one spanning…
FINANCE.YAHOO.COM
·
2026-06-11
LOW
NEUTRAL
CORR0.42
Is ResMed Inc. (RMD) A Good Stock To Buy Now?
$RMD
◈ ESEN AI
ResMed Inc. (RMD) is the subject of this valuation-focused analysis, presenting a neutral signal in the current market environment. The article examines a bullish thesis circulating in retail investor forums, suggesting…
SEEKINGALPHA.COM
·
2026-06-11
NEUTRAL
BULLISH
CORR0.42
ResMed: GLP-1 Threats Are Overstated (NYSE:RMD)
$RMD
◈ ESEN AI
ResMed (RMD) faces recurring concerns about GLP-1 drug adoption eroding its core sleep apnea and respiratory care markets. This analysis contests that narrative, arguing that while some market share migration is inevita…
EXPLORE OTHER FILTERS